US Stock MarketDetailed Quotes

BMRN Biomarin Pharmaceutical

Watchlist
  • 66.940
  • +0.790+1.19%
Close Nov 7 16:00 ET
  • 67.770
  • +0.830+1.24%
Post 17:01 ET
12.76BMarket Cap40.33P/E (TTM)

Biomarin Pharmaceutical Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Nov 7, 2024

Based on 29 analysts giving stock ratings to Biomarin Pharmaceutical in the past 3 months

Buy

  • Buy

    72.41%
  • Hold

    27.59%
  • Sell

    0.00%

Price Target

Updated: Nov 7, 2024

The average Biomarin Pharmaceutical stock price target is 99.64 with a max estimate of 139.00 and a min estimate of 72.00

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Nov 7, 2024

Buy

  • Buy

    72.41%
  • Hold

    27.59%
  • Sell

    0.00%

Price Target

Updated: Nov 7, 2024

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data